PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
|Articles|January 2, 2017
- Pharmaceutical Technology-01-02-2017
- Volume 41
- Issue 1
Automatic Purge System for Control Panels
The Ross SysCon control panels can now be supplied with a fully automatic Type X Purge System, which forces clean air through the enclosure until all hazardous gases are removed.
The Ross SysCon control panels from Ross, Charles & Son can now be supplied with a fully automatic Type X Purge System, which forces clean air through the enclosure until all hazardous gases are removed. The system then maintains a slight positive pressure within the panel. The Type X Purge System includes a 24-volt power supply. The UL-listed Operator Stations are designed for use with a remote PLC System to ensure full operational functionality of the equipment they control.
Articles in this issue
over 9 years ago
Predicting Moisture Uptake in Solid Dosage Packagingover 9 years ago
Blister Packaging Moves Forwardover 9 years ago
Staffing and Preparation for Auditsover 9 years ago
Fully Automated Capping Systemsover 9 years ago
Spray Dryer for Efficient Microencapsulationover 9 years ago
Vials Reduce Risk of Drug Container Interactionsover 9 years ago
The Tide Stays Highover 9 years ago
Drug Quality Key to Innovation and Accessover 9 years ago
FDA New Drug Approvals Down Significantly in 2016over 9 years ago
Beyond Distractions, Pharma Moves OnRelated to this article
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Karthik Iyer, Eli Lilly, details an AI system linking GMP findings, audits, and deviations for cited, inspection-ready regulatory intelligence.